Docket
16/324,836,
U.S. Patent Application
(Feb. 11, 2019)
Art Group | 1634 |
Case Type | Utility - 435/006110 |
Class | 435 |
Inventor | Ignacio PINO |
Inventor | Heng ZHU |
Applicant | CDI LABORATORIES, INC. |
Cite Docket
COMPOSITIONS AND METHODS FOR ANALYZING NUCLEIC ACIDS ASSOCIATED WITH AN ANALYTE, 16/324,836 (U.S. Pat. App.)
+ More Snippets
Document
IPR2019-00449, No. 3 Notice of Filing Date Accorded to Petition - Notice of Accord Filing Date (P.T.A.B. Feb. 6, 2019)
For more information, please consult the Office Patent Trial Practice Guide, 77 Fed. Reg. 48756 (Aug. 14, 2012), which is available on the Board Web site at http://www.uspto.gov/PTAB.
Patent Owner is advised of the requirement to submit mandatory notice information under 37 C.F.R. § 42.8(a)(2) within 21 days of service of the petition.
The parties are advised that under 37 C.F.R. § 42.10(c), recognition of counsel pro hac vice requires a showing of good cause.
Many non-profit organizations, both inside and outside the intellectual property field, offer alternative dispute resolution services.
If the parties actually engage in alternative dispute resolution, the Case IPR2019-00449 Patent No. 9,763,876 PTAB would be interested to learn what mechanism (e.g., arbitration, mediation, etc.) was used and the general result.
Cite Document
IPR2019-00449, No. 3 Notice of Filing Date Accorded to Petition - Notice of Accord Filing Date (P.T.A.B. Feb. 6, 2019)
+ More Snippets
Document
IPR2019-00450, No. 4 Notice of Filing Date Accorded to Petition - Notice of Accord Filing Date (P.T.A.B. Feb. 6, 2019)
For more information, please consult the Office Patent Trial Practice Guide, 77 Fed. Reg. 48756 (Aug. 14, 2012), which is available on the Board Web site at http://www.uspto.gov/PTAB.
Patent Owner is advised of the requirement to submit mandatory notice information under 37 C.F.R. § 42.8(a)(2) within 21 days of service of the petition.
The parties are advised that under 37 C.F.R. § 42.10(c), recognition of counsel pro hac vice requires a showing of good cause.
Many non-profit organizations, both inside and outside the intellectual property field, offer alternative dispute resolution services.
If the parties actually engage in alternative dispute resolution, the Case IPR2019-00450 Patent No. 9,763,876 PTAB would be interested to learn what mechanism (e.g., arbitration, mediation, etc.) was used and the general result.
Cite Document
IPR2019-00450, No. 4 Notice of Filing Date Accorded to Petition - Notice of Accord Filing Date (P.T.A.B. Feb. 6, 2019)
+ More Snippets
Docket
16/322,889,
U.S. Patent Application
(Feb. 1, 2019)
Art Group | 1647 |
Case Type | Utility - 424/133100 |
Class | 424 |
Inventor | Xin DU |
Inventor | Justin CHAPMAN |
Inventor | Marc NASOFF |
Cite Docket
ERFE SPECIFIC ANTIBODIES COMPOSITIONS AND METHODS OF USE, 16/322,889 (U.S. Pat. App.)
+ More Snippets
Docket
16/264,420,
U.S. Patent Application
(Jan. 31, 2019)
Cite Docket
MULTILAYER DENTAL APPLIANCES AND RELATED METHODS AND SYSTEMS, 16/264,420 (U.S. Pat. App.)
+ More Snippets
Docket
16/320,729,
U.S. Patent Application
(Jan. 25, 2019)
Cite Docket
CELL THERAPY COMPOSITIONS AND METHODS OF USE THEREOF, 16/320,729 (U.S. Pat. App.)
+ More Snippets
Docket
16/317,750,
U.S. Patent Application
(Jan. 14, 2019)
Cite Docket
HISTONE DEACETYLASE INHIBITORS FOR USE IN IMMUNOTHERAPY, 16/317,750 (U.S. Pat. App.)
+ More Snippets
Docket
16/245,564,
U.S. Patent Application
(Jan. 11, 2019)
Cite Docket
THERAPEUTIC AND METHOD OF USE, 16/245,564 (U.S. Pat. App.)
+ More Snippets
Docket
16/315,365,
U.S. Patent Application
(Jan. 4, 2019)
Cite Docket
PDE9 INHIBITORS FOR TREATMENT OF PERIPHERAL DISEASES, 16/315,365 (U.S. Pat. App.)
+ More Snippets
Docket
16/312,901,
U.S. Patent Application
(Dec. 21, 2018)
Cite Docket
NOVEL NUCLEOSIDE TRIPHOSPHATE TRANSPORTER AND USES THEREOF, 16/312,901 (U.S. Pat. App.)
+ More Snippets
Docket
16/312,168,
U.S. Patent Application
(Dec. 20, 2018)
Cite Docket
METHODS FOR DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES, 16/312,168 (U.S. Pat. App.)
+ More Snippets
Document
IPR2019-00451, No. 42 Reply - Patent Owners Reply to Petitioner¿¿¿s Opposition to Patent Owner¿¿¿s Motion to Exclude Evidence (P.T.A.B. May. 5, 2020)
Cite Document
IPR2019-00451, No. 42 Reply - Patent Owners Reply to Petitioner¿¿¿s Opposition to Patent Owner¿¿¿s Motion to Exclude Evidence (P.T.A.B. May. 5, 2020)
+ More Snippets
Document
IPR2019-00451, No. 41 Reply - PETITIONERS REPLY IN SUPPORT OF ITS MOTION TO EXCLUDE EVIDENCE (P.T.A.B. May. 5, 2020)
Cite Document
IPR2019-00451, No. 41 Reply - PETITIONERS REPLY IN SUPPORT OF ITS MOTION TO EXCLUDE EVIDENCE (P.T.A.B. May. 5, 2020)
+ More Snippets
Document
IPR2019-00451, No. 39 Opposition - Patent Owners Opposition to Petitioners Motion to Exclude (P.T.A.B. Apr. 28, 2020)
Cite Document
IPR2019-00451, No. 39 Opposition - Patent Owners Opposition to Petitioners Motion to Exclude (P.T.A.B. Apr. 28, 2020)
+ More Snippets
Document
IPR2019-00451, No. 38 Opposition - PETITIONERS OPPOSITION TO PATENT OWNERS MOTION TO EXCLUDE EVIDENCE (P.T.A.B. Apr. 28, 2020)
Cite Document
IPR2019-00451, No. 38 Opposition - PETITIONERS OPPOSITION TO PATENT OWNERS MOTION TO EXCLUDE EVIDENCE (P.T.A.B. Apr. 28, 2020)
+ More Snippets